CD40 and neoplasm: Thus, we hypothesize that CD8+ T cells recognize tumor antigens presented by the cancer cells via MHC-I, whereupon they become activated and express CD40L, which directly triggers noncanonical cytotoxicity in CD40+ cancer cells.